ArticleHeliyon2024
An exponentiated XLindley distribution with properties, inference and applications.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development of a novel extension of Rayleigh distribution with application to COVID-19 data.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, we propose exponentiated XLindley (EXL) distribution. The novel model is adaptable due to the mixt shapes of its density and failure rate functions. The following key statistical properties of EXL distribution are derived: quantile function, moments, hazard function, mean residual life, and Rényi entropy. The parameters are estimated using the maximum likelihood, Anderson Darling, Cramer von Misses, maximum product spacing, ordinary and weighted least square estimation procedures. To examine the behavior of the estimate, Monte Carlo simulation is used. Further Bayesian technique is also utilized to estimate the EXL parameters. The traceplot and Geweke diagnostics are used to track the convergence of simulated processes. The applicability of the EXL distribution is demonstrated by three datasets from different domains such as mortality rate due to COVID-19, precipitation in inches, and failure time for repairable items. The proposed distribution provides efficient results as compared to renowned competitive distributions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.